Novartis: Hypertension trials

The registry lists 227 Hypertension studies with Novartis as lead sponsor. 4 are open to participants now and 88 have results posted.

Phase 1 18Phase 2 31Phase 3 109Phase 4 67No phase 4(a study in two phases counts in both)

Studies

Page 3 of 3. Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study Comparing the Response of Patients With Hypertension to Amlodipine or Amlodipine Plus Benazepril.CompletedNCT00171366Phase 3
• A Study to Describe Vascular and Renal Effects and Safety of Valsartan in Patients With High Blood PressureCompletedNCT00171353Phase 4
• Efficacy and Safety of Fluvastatin or Valsartan and Their Combination in Dyslipidemic Patients With Hypertension and Endothelial DysfunctionCompletedNCT00171327Phase 4
• VALENCE: Valsartan Versus Atenolol on Exercise Capacity in Hypertensive Overweight Postmenopausal WomenCompletedNCT00171132Phase 4
• A Study in Patients With Diabetes Mellitus Type II of the Effect on Albuminuria of 24 Week Treatment With Valsartan, Benazepril, and Valsartan+BenazeprilTerminatedNCT00171119Phase 4
• A 10-12 Week Study to Evaluate the Safety and Efficacy of 320 mg Valsartan and 80 mg Simvastatin in Combination and as Monotherapies in Treating Hypertension and HypercholesterolemiaCompletedNCT00171093Phase 3
• VALID: Study to Compare the Reduction of Predialysis Systolic Blood Pressure With Valsartan Compared to Irbesartan in Patients With Mild to Moderate Hypertension on Long-term HemodialysisCompletedNCT00171080Phase 3
• VALERIA: Valsartan in Combination With Lisinopril in Hypertensive Patients With MicroalbuminuriaCompletedNCT00171067Phase 3
• A Study Of Valsartan Used To Treat Hypertension For Up To 13 Months In Hypertensive Children Ages 6 - 16 Years Of AgeCompletedNCT00171041Phase 3
• A Study Of Valsartan Used To Treat Hypertension For Up To 56 Weeks In Children Ages 1 - 5 Years Who Have HypertensionCompletedNCT00171028Phase 3
• VALORY Study of Valsartan/Hydrochlorizide for Patients Who do Not Respond Adequately to Olmesartan MedoxomilCompletedNCT00171015Phase 3
• Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Amlodipine AloneCompletedNCT00171002Phase 3
• Valsartan/Hydrochlorothiazide Combination in Hypertensive Patients Not Controlled With Valsartan AloneCompletedNCT00170989Phase 3
• A Year Long Study to Evaluate the Safety of the Combination of Valsartan (320 mg) and Amlodipine (5 mg) in Patients With HypertensionCompletedNCT00170976Phase 3
• Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Valsartan AloneCompletedNCT00170963Phase 3
• A 16 Week Study to Evaluate the Effect on Insulin Sensitivity of Valsartan (320 mg) and Hydrochlorothiazide (25 mg) Combined and Alone, in Patients With Metabolic SyndromeCompletedNCT00170937Phase 4
• To Find Out Whether Valsartan With or Without Other Blood Pressure Medications Would Improve the Ability of the Heart to Fill and Empty, and the Ability of the Heart Muscle to Relax Adequately in People With High Blood Pressure.CompletedNCT00170924Phase 4
• Effects of Blood Pressure Reduction on High Sensitivity C-Reactive Protein (hsCRP)CompletedNCT00154271Phase 4
• Effects of Amlodipine/Benazepril in Reducing Left Ventricular Hypertrophy in Patients With High Risk HypertensionCompletedNCT00139555Phase 4
• Study Comparing the Efficacy of Amlodipine Besylate/Benazepril Versus Amlodipine in the Treatment of Severe HypertensionCompletedNCT00136851Phase 4
• Effects of Amlodipine/Benazepril on Albuminuria in Hypertensive Patients With Type 2 Diabetes MellitusCompletedNCT00136773Phase 4
• Safety and Efficacy of Aliskiren When Added to Standardized Losartan and Optimal Antihypertensive Therapy in Patients With Hypertension, Type 2 Diabetes and ProteinuriaCompletedNCT00097955Phase 2
• Clevidipine in the Postoperative Treatment of Hypertension (ECLIPSE-NIC)CompletedNCT00093925Phase 3
• Clevidipine in the Perioperative Treatment of Hypertension (ECLISPE-SNP)CompletedNCT00093912Phase 3
• Clevidipine in the Perioperative Treatment of Hypertension (ECLIPSE-NTG)CompletedNCT00093886Phase 3
• Study of Clevidipine Assessing Its Postoperative Antihypertensive Effect in Cardiac Surgery (ESCAPE-2)CompletedNCT00093262Phase 3
• Study of Clevidipine Assessing Its Preoperative Antihypertensive Effect in Cardiac Surgery (ESCAPE-1)CompletedNCT00093249Phase 3